Conference Program






“The National Association of Biobanks and Biobanking Specialists is a key element in the development of biobanking in Russia”


APRIL 9, 2019


First symposium — 9:00-10:35;

Second symposium — 10:50-12:15;

Third symposium — 12:45-14:00 — Meeting of members of NASBio (closed event)


Co-Chairs: O.M. Drapkina, I.V. Korobko, E. Steinfelder, D. Simeon-Dubach,

S.A. Boytsov, S.M. Yudin, V.A. Tkachuk, A.L. Ginzburg, A.D. Kaprin,

S.V. Anisimov, A.N. Meshkov


First Symposium

  1. Oxana Drapkina, President, NASBio; Director of National Medical Research Center for Preventive Medicine (Moscow); corresponding member, Russian Academy of Sciences. Welcome speech on behalf of the National Association of Biobanks and biobanking specialists (NASBio). Lecture: “Foundation of the National Association of Biobanks – essential step in the development of biomedical research in Russia. Role in the development of personalized medicine» (20 minutes)
  2. Daniel Simeon-Dubach, Chair of ISBER Standards Committee (Switzerland): “The current global status of biobanking and prospects for further development” (20 minutes)
  3. Erik Steinfelder, Director General of BBMRI-ERIC (Austria): “Personalized Medicine and the role of biobanking — call to action” (20 minutes)
  4. Andrey Kaprin, Director General of National Medical Research Radiology Center (Obninsk); member, Russian Academy of Sciences: “Biobanks and creation of systematized collections of biospecimens — key instrument for the discovery of new biomarkers and therapeutic targets for oncological diseases” (20 minutes)



  1. Vitali Proutski, CEO, National BioService (St.-Petersburg): “Biobanks as catalysts for biomedical R&D – platform of the National Technological Initiative for the creation of biobanking network” (15 minutes)


break (15 minutes)


Second symposium

  1. Yann Joly, Research Director of the Centre of Genomics and Policy (CGP), McGill University, Canadian Commission for UNESCO (Canada): “Three key policy challenges over the lifecycle of a biobank: communication with participants, international sharing and closure” (20 minutes)
  2. Olga Kofanova, Team Leader Biospecimen Quality, IBBL, Integrated BioBank of Luxembourg: “Quality control of biospecimens – an essential tool in the work of biobanks. Best Practices” (20 minutes)
  3. Anastasia Efimenko, Head of Laboratory for reparation and tissue regeneration, Institute of Regenerative Medicine, Medical Research and Educational Center, M.V.Lomonosov Moscow State University (Moscow): “The value of biobanking for the development of regenerative medicine” (15 minutes)
  4. Kirill Volkov, Acting Director of the Research Center “Biobank”, St.-Petersburg State University (St. Petersburg): “Biobank within the structure of the Research Park of St.-Petersburg State University” (15 minutes)
  5. Svetlana Apalco, Head of Bio-banking and translational biomedicine sector, St.-Petersburg City Hospital #40, (St.-Petersburg): “Biobanks as a strategic area of ​​public health activities. Tissue biobanks — a source of new biomarkers and molecular targets for diagnostics and treatment of oncological diseases” (15 minutes)
  6. Yulia Nasykhova, Senior Researcher, Laboratories of biobanking and genomic medicine, Institute of translational biomedicine, St.-Petersburg State University (St.-Petersburg): “Creating a biobank of a biomaterial of patients with type 2 diabetes as part of an international project – the prospects of impact upon regional healthcare” (15 minutes)
  7. Anastasia Shatalova, Deputy director on perspective development of medical services, National Medical Research Center for Preventive Medicine (Moscow): “Quality Management in a Biobank: world trends and experience of the Biobank of the NMRC for Preventive Medicine” (15 minutes)